Immune Checkpoints in Cancer Treatment

Authors

Matthew A. Cherubino, Gettysburg CollegeFollow

Class Year

2022

Document Type

Poster

Date of Creation

Fall 2018

Department 1

First Year Seminar

Department 2

Chemistry

Abstract

Despite the human immune system, cancer thrives in an extremely hostile environment. Cancer is the second most common cause of death in the U.S. with about 600,000 deaths every year, and cancer is expected to surpass heart disease as the most common cause of death in the U.S. Immune checkpoint inhibitors are a novel and promising therapeutic for treating cancer in its late stages.

Comments

Created for FYS 155-2: Cancer in Society: A War Against Immortality and presented at the 2019 Celebration of Academic First-Year Engagement Symposium.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Recommended Citation

Cherubino, Matthew A., "Immune Checkpoints in Cancer Treatment" (2018). Student Publications. 677.
https://cupola.gettysburg.edu/student_scholarship/677